167 related articles for article (PubMed ID: 9783328)
1. Apoptosis in embryos of diabetic rats.
Forsberg H; Eriksson UJ; Welsh N
Pharmacol Toxicol; 1998 Sep; 83(3):104-11. PubMed ID: 9783328
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats.
Zabihi S; Eriksson UJ; Wentzel P
Reprod Toxicol; 2007 Jun; 23(4):486-98. PubMed ID: 17482424
[TBL] [Abstract][Full Text] [Related]
3. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327
[TBL] [Abstract][Full Text] [Related]
4. Nitroxide radicals protect cultured rat embryos and yolk sacs from diabetic-induced damage.
Ryu S; Kohen R; Samuni A; Ornoy A
Birth Defects Res A Clin Mol Teratol; 2007 Aug; 79(8):604-11. PubMed ID: 17626261
[TBL] [Abstract][Full Text] [Related]
5. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies.
Ornoy A; Zaken V; Kohen R
Teratology; 1999 Dec; 60(6):376-86. PubMed ID: 10590399
[TBL] [Abstract][Full Text] [Related]
6. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
Chen B; Cyr DG; Hales BF
Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
[TBL] [Abstract][Full Text] [Related]
7. Aberrant patterns of cellular communication in diabetes-induced embryopathy in rats: II, apoptotic pathways.
Reece EA; Ma XD; Zhao Z; Wu YK; Dhanasekaran D
Am J Obstet Gynecol; 2005 Mar; 192(3):967-72. PubMed ID: 15746699
[TBL] [Abstract][Full Text] [Related]
8. Teratogen-induced activation of the mitochondrial apoptotic pathway in the yolk sac of day 9 mouse embryos.
Soleman D; Cornel L; Little SA; Mirkes PE
Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):98-107. PubMed ID: 12769505
[TBL] [Abstract][Full Text] [Related]
9. The effects of high-sucrose diets and of maternal diabetes on the ultrastructure of the visceral yolk sac endoderm in rat embryos developing in vivo and in vitro.
Zusman I; Yaffe P; Ornoy A
Acta Anat (Basel); 1987; 128(1):11-8. PubMed ID: 2950713
[TBL] [Abstract][Full Text] [Related]
10. Cadmium-induced rat embryotoxicity in vitro is associated with an increased abundance of E-cadherin protein in the yolk sac.
Chen B; Hales BF
Toxicol Appl Pharmacol; 1994 Oct; 128(2):293-301. PubMed ID: 7940544
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of active caspase-3 and DNA fragmentation (TUNEL) in normal and hyperthermia-induced abnormal mouse development.
Mirkes PE; Little SA; Umpierre CC
Teratology; 2001 Mar; 63(3):134-43. PubMed ID: 11283970
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and its pathway in early post-implantation embryos of diabetic rats.
Sun F; Kawasaki E; Akazawa S; Hishikawa Y; Sugahara K; Kamihira S; Koji T; Eguchi K
Diabetes Res Clin Pract; 2005 Feb; 67(2):110-8. PubMed ID: 15649569
[TBL] [Abstract][Full Text] [Related]
13. Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos.
Yang X; Borg LA; Simán CM; Eriksson UJ
Anat Rec; 1998 Jul; 251(3):303-15. PubMed ID: 9669757
[TBL] [Abstract][Full Text] [Related]
14. Cellular-tissue localization and regulation of the GLUT-1 protein in both the embryo and the visceral yolk sac from normal and experimental diabetic rats during the early postimplantation period.
Trocino RA; Akazawa S; Takino H; Takao Y; Matsumoto K; Maeda Y; Okuno S; Nagataki S
Endocrinology; 1994 Feb; 134(2):869-78. PubMed ID: 8299581
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Yp subunit of glutathione S-transferase P in rat embryos and yolk sacs during organogenesis.
Hales BF; Huang C
Biochem Pharmacol; 1994 Jun; 47(11):2029-37. PubMed ID: 8010987
[TBL] [Abstract][Full Text] [Related]
16. Rat visceral yolk sac cells: viability and expression of cell markers during maternal diabetes.
Aires MB; Santos JR; Souza KS; Farias PS; Santos AC; Fioretto ET; Maria DA
Braz J Med Biol Res; 2015 Aug; 48(8):676-82. PubMed ID: 26176314
[TBL] [Abstract][Full Text] [Related]
17. Embryopathy in experimental diabetic gestation: assessment of PGE2 level, gene expression of cyclooxygenases and apoptosis.
El-Bassiouni EA; Helmy MH; Abou Rawash N; El-Zoghby SM; Kamel MA; Abou Raya AN
Br J Biomed Sci; 2005; 62(4):161-5. PubMed ID: 16411374
[TBL] [Abstract][Full Text] [Related]
18. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
Khandelwal M; Reece EA; Wu YK; Borenstein M
Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
[TBL] [Abstract][Full Text] [Related]
19. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis.
Reece EA; Ji I; Wu YK; Zhao Z
Am J Obstet Gynecol; 2006 Oct; 195(4):1075-80. PubMed ID: 17000240
[TBL] [Abstract][Full Text] [Related]
20. Beta-hydroxybutyrate increases reactive oxygen species in late but not in early postimplantation embryonic cells in vitro.
Forsberg H; Eriksson UJ; Melefors O; Welsh N
Diabetes; 1998 Feb; 47(2):255-62. PubMed ID: 9519722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
